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ABSTRACT
Base excision repair (BER) is the main pathway for
repair of DNA damage in mammalian cells. This path-
way leads to the formation of DNA repair intermedi-
ates which, if still unsolved, cause cell lethality and
mutagenesis. To characterize mutations induced by
BER intermediates in mammalian cells, an SV-40
derived shuttle vector was constructed carrying a
site-specific lesion within the recognition sequence
ofarestrictionendonuclease.Themutationspectraof
abasic(AP)sites,50-deoxyribose-5-phosphate(50dRp)
and 30-[2,3-didehydro-2,3-dideoxy-ribose] (30ddR5p)
single-strand breaks (ssb) in mammalian cells was
analysed by RFLP/PCR and mutation frequency was
estimated by quantitative PCR. Point mutations were
the predominant events occurring at all BER interme-
diates. The AP site-induced mutation spectrum sup-
ports evidence for the ‘A-rule’ and is also consistent
with the use of the 50 neighbouring base to instruct
nucleotide incorporation (50-rule). Preferential aden-
ine insertion was also observed after in vivo replica-
tion of 50dRp or 30ddR5p ssb. We provide original
evidencethatnotonlytheabasicsitebutalsoitsderiv-
atives ‘faceless’ BER intermediates are mutagenic,
with a similar mutation frequency, in mammalian
cells. Our findings support the hypothesis that unat-
tended BER intermediates could be a constant threat
for genomeintegrityaswell asaspontaneous source
of mutations.
INTRODUCTION
The cellular genome stability is constantly threatened by the
exposure to endogenous and exogenous agents: alkylating
agents, reactive oxygen species and UV-light alter the
DNA primary structure. The majority of DNA lesions lead
to immediate adverse consequences, such as cell lethality and
mutagenesis. In order to limit the deleterious effect of DNA
damage, cells are provided of numerous DNA repair mech-
anisms, including nucleotide excision repair (NER), base
excision repair (BER), mismatch repair (MMR), recombina-
tion and translesion DNA synthesis (TLS). BER is the major
repair mechanism involved in the removal of structurally
non-distorting and non-bulky lesions, such as oxidized and
alkylated bases, deaminated bases and apurinic/apyrimidinic
(AP) sites (1). BER is a multi-enzymatic pathway initiated by
DNA glycosylases that are able to remove the modiﬁed base
bycleavage of the N-glycosydic bond giving rise to an AP site.
The hydrolytic cleavage by monofunctional DNA glyc-
osylases leads to release of the damaged base and the forma-
tion of an AP site, subsequently converted to a single-strand
break (ssb) by an AP endonuclease. This activity hydrolyses
the phosphodiester DNA backbone 50 to the AP site leading
to 30-hydroxyl (30OH) and 50-deoxyribose-5-phosphate
(50dRp) termini. The removal of the 50dRp residue, which
is essential for the ligation reaction, is catalysed by the
50dRp lyase activity of DNA polymerase (pol) b. Bifunctional
DNA glycosylases present an associated lyase activity that
catalyses the cleavage of the DNA phosphodiester backbone
via a b-elimination reaction leaving 30-[2,3-didehydro-
2,3-dideoxy-ribose] (30ddR5p) and 50 phosphate termini (2).
The 30ddR5p terminus, brieﬂy referred as 30-ab-unsaturared
aldehyde, is removed by the 30 phosphodiesterase activity
of AP endonuclease 1 (APE 1) to generate a suitable substrate
for ligation. The BER reaction can be completed by either
short patch (SP-BER) or long patch (LP-BER) repair syn-
thesis. In the SP-BER, the single nucleotide gap is ﬁlled by
pol b, and X-ray repair cross complementing group I (XRCC
I)/LIG III restores DNA strand integrity. Replicative DNA
pol d and e can replace pol b in the LP-BER. DNA pol d
and e displace the 50dRp-containing strand and synthesize
longer repair patches. Additional players, FEN I, PCNA,
RFC and DNA ligase I, are implicated in this pathway.
Reduced or oxidized abasic sites, known to be resistant to
the dRp-lyase activity of pol b, are mainly processed by
LP-BER (3).
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doi:10.1093/nar/gki749In the last years, biochemical studies have shown numerous
protein–protein interactions among SP- and LP-BER enzymes
that led to consider this repair mechanism as an orchestrated
process. This might be a requisite to avoid the exposure of
highly reactive repair intermediates (4).
The co-ordination among BER components is exempliﬁed
by the role of XRCC I, a scaffold protein able to interact with
all the enzymes involved in BER following the glycosylase
step, such APE 1, DNA pol b and LIG III. XRCC I could be
recruited by the lesion speciﬁc glycosylase and then recall the
downstream players to repair intermediates (5).
Another example is poly(ADP–ribose) polymerase-1
(PARP 1). Photoafﬁnity studies showed that PARP 1 is a
member of a multi-enzymatic complex which binds to BER
intermediates resistant to b-elimination reactions, namely
50-incised tetrahydrofuran (THF) abasic sites (6). After 50ssb
interaction, PARP 1 seems to stimulate strand displacement
synthesis by pol b and ﬂap cleavage by FEN I implying a role
of this protein in LP-BER reactions. The biological relevance
of a highly co-ordinated BER process is also testiﬁed by recent
data that suggest that persistence of ‘unattended’ BER inter-
mediates in the genome is potentially harmful for the cell.
Mouse myeloid progenitor bone marrow cells deﬁcient for
N-alkylpurine-DNA-glycosylase (7) show increased resist-
ance to alkylation damage, and mouse ﬁbroblasts defective
in the lyase activity of DNA pol b are hypersensitive to the
cytotoxic and mutagenic effects of alkylation damage (8).
Differentmechanismsare expected tohave arole inAPsite-
induced mutagenesis. In Escherichia coli cells, it has been
shown that not only the SOS-dependent TLS is responsible
for mutagenesis of chromosomal AP sites, but BER and
recombination also play a role (9). In mammalian cells, the
crucial role of BER to limit the mutagenic potential of the
abasic sites is clearly testiﬁed by the increased spontaneous
and alkylation damage-induced mutation frequency observed
in pol b-defective cells (10). BER synthesis per se gives a
minor contribution to mutagenesis (11,12). In vitro studies on
the bypass ability of puriﬁed eukaryotic Y-family DNA poly-
merases strongly suggest the involvement of TLS in AP site-
induced mutagenesis in mammalian cells too. However, the
relative contribution of TLS to the in vivo mutagenesis of AP
sites and the identiﬁcation of the involved DNA polymerase
remain to be elucidated. Finally, stalled DNA replication forks
at unrepaired AP sites and non-canonical ssb (i.e. 50dRp and
30ddRp) could be a signal for recombination events. Recently,
homologous recombination at double-strand breaks (dsb)
arising from unrepaired ssb has been evoked to protect
mammalian cells from BER-intermediates-induced cytotoxic
effect (13,14).
The mutational speciﬁcity of the base loss sites in living
cells has been extensively investigated. In bacteria, these
lesions become mutagenic under the SOS response and a
preferential insertion of an adenine was observed (‘A-rule’).
Conversely, in Saccharomyces cerevisiae the tendency for
the insertion of dCMP opposite the AP site was found
(‘C-rule’) (15).
In mammalian systems, controversial reports either suggest
no speciﬁcity in the insertion of dNTPs opposite the base loss
site or the ‘A-rule’ signature (16,17). No data are available on
the mutagenic speciﬁcity of other BER repair intermediates,
such as the 50dRp and 30ddR5p termini.
More recently, the mutational speciﬁcity of AP sites has
been reanalysed following the discovery of a new family of
DNA polymerases (Y-family) that successfully replicate dam-
aged DNA templates, such as pol h, pol i, pol k and Rev1 (18).
Numerous in vitro studies strongly suggest that DNA polh can
be involved in the TLS of the abasic sites. Using puriﬁed
human pol h, an efﬁcient bypass of AP sites was reported
and a preferential insertion of purines was found (13). The
interaction between PCNA and pol h strongly increased its
bypass ability and a more efﬁcient extension reaction was
observed from an A opposite the AP site than from a G oppos-
ite this lesion (14,19). More recently, Kokoska et al. (20)
showed that human pol h and Sulfolobus solfataricus DNA
polymerase 4 (Dpo4), a human pol k homologue, efﬁciently
bypassed abasic sites showing a strong bias for the adenine
insertion.
To study the mutagenic potential of BER intermediates in
mammalian cells we constructed single lesion-containing
SV40-derived vectors presenting either an AP site or a 50dRp
or a 30ddR5p sugar moiety at a deﬁned position of their
genome. The molecular nature of mutations was established
after vector progeny rescue from simian cells. We were able
to conﬁrm the ‘A’ signature for abasic sites-induced muta-
tions in mammalian cells and provide original evidence that
AP sites derivatives 30 or 50 blocked ssb are also mutagenic.
We hypothesise that restart of stalled forks can occur at BER
intermediates thus leading to mutational events.
MATERIALS AND METHODS
Chemicals
Chemicals were purchased from Sigma. T4 DNA polymerase,
T4 DNA ligase and T4 gene 32 protein were purchased from
Roche Molecular Biochemicals. Restriction enzymes were
from New England Biolabs.
Preparation of DNA substrates
The shuttle vector used in this study, pC2, is a derivative of
phagemid pGEM-3Zf(+) and pSV-ori. To obtain pC2, the
pGEM phagemid (Promega, Madison, WI) was digested
withNdeIandScaItoreleasethef1phageorigin,whichallows
the rescue of single-stranded molecules. Before ligation step,
the NdeI site was ﬁlled in with Klenow fragment enzyme.
pSVori was digested with ScaI and AccI; this fragment con-
tains the SV40 replication origin necessary to allow the vector
replication after transfection in COS cells.
Oligonucleotides for in vitro replication assay were pur-
chased from Life Technologies. Closed circular DNA contain-
ing a single lesion was produced as described previously (21)
by priming single-stranded (+) pGEM-3Zf DNA with 30-fold
molar excess of lesion-containing oligonucleotide and incub-
ating with T4 DNA polymerase holoenzyme, single-stranded
DNA binding protein and T4 DNA ligase. Single-stranded
DNA of the pGEM plasmid was produced according to the
manufacturer’s instruction using the M13K07 helper phage.
Closed circular DNA duplex molecules were puriﬁed by
caesium chloride equilibrium centrifugation. The oligonuc-
leotide 50-GAT CCT CTA GAG TCG HX CC TGC A-30
was used to create molecules containing a single hypoxanthine
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pGEM molecule was 50-TGCAGGTCGACTCTAGAG-
GATC-30. By this construction scheme, the lesion is located
on the lagging strand. Circular closed DNA molecules were
digested with human monofunctional 3-methyladenine DNA
glycosylase, the ANPG protein (a gift from Dr M. Saparbaev,
CNRS, Institut Gustave Roussy, Villejuif Cedex, France) to
produce a single AP site. 50dRp and 30ddR5p residue-
containing plasmids were created by APE 1 digestion (a
giftfromDr I. D.Hickson,John RodcliffeHospital, University
of Oxford, UK) and E.coli nth endonuclease (a gift from Dr S.
Boiteux, Centre Energie Atomique, Fontenay aux Roses,
France), respectively.
Cell culture and transfection
Monkey COS7 cells were grown as monolayers in DMEM
(Gibco), supplemented with 10% fetal calf serum (Flow
Laboratories), penicillin and streptomycin in 5% CO2 incub-
ator. The plasmid pC2 was introduced into the cells by the
calcium phosphate coprecipitation technique and the precip-
itate was left on the cells overnight. Three days after trans-
fection, the cells were collected and the SV40-derived shuttle
vectors were recovered by Hirt procedure. To make sure that
only plasmid molecules that replicated in mammalian cells
were used as substrates for RFLP/PCR, the pC2 molecules
recovered after transfection in COS cells were extensively
digested by DpnI prior to ampliﬁcation.
Selection for mutations in SalI recognition sequence of
pC2 molecules by RFLP/PCR
In our shuttle vectors, the single lesion is located within the
recognition sequence of speciﬁc restriction endonucleases
(SalI/AccI/HincII) thus allowing recovery of mutants by
restriction fragment length polymorphism PCR (RFLP/
PCR) technique. An aliquot of 1 ng of pC2 DNA or aliquots
of the shuttle vector DNA isolated from COS cells were
extensively digested with the selected restriction endonuc-
lease. Three rounds of 1 h digestion with 20 U of SalI were
performed and the restricted DNA was puriﬁed by drop dia-
lysis for 30 min at 4 C. The vector molecules resistant to
cleavage were then ampliﬁed by PCR. The sequences of
the primers were forward 50-GCCAGTGAATTGTAA-
TACG-30 and reverse 50-CTGTGGATAACCGTATTACC
GC-30.The resulting PCR product contained the multipleclon-
ing sites region of pC2, where the lesion of interest was ini-
tiallylocated. PCRwas performed by adding 2.5UofTaq gold
polymerase (Applied Biosystems) according to the standard
conditions. The cycle proﬁle was as follows: (i) 94 C for 1
min; (ii) 55 C for 2 min; (iii) 70 C for 3 min. After 20 cycles
of ampliﬁcation, a small aliquot (1/10) of the PCR was
checked on agarose gel and, if necessary, other 10 cycles of
ampliﬁcation were applied. The ampliﬁed molecules were
further digested and, if a partial contamination of sensitive/
wild-type molecules was still present, the resistant/mutated
molecules were separated on agarose gel and puriﬁed by
gel puriﬁcation kit (Qiagen). PCR molecules were cloned
by TA cloning kit PCR II (Invitrogen) and sequenced. Mutants
were sequenced with AmpliTaqFS on an ABI Prism 310 auto-
matic sequencer (Perkin Elmer, Milano, Italy)
Quantitative PCR
Relative standard curve approach was employed and serial
dilutions of pC2 DNA (dilution values from 10
 1 to 10
 9 ng)
were used to construct a titration curve. For all experi-
mental samples,  1 ng of pC2 DNA, rescued by Hirt proced-
ure after transient transfection of different adducted substrates,
was ampliﬁed contextually to SalI-digested pC2 samples. All
ampliﬁcation reaction were carried out by the ABI PRISM
7700 Sequence Detection System. The sequences of the
primers and probe were forward 50-AATACGACTCACTA-
TAGGGCGAATTC-30, reverse 50-TGACCATGATTACG-
CCAAGCT-30 and probe 50-CTCTAGAGGATCCCC-30.
The cycle proﬁle was according to the manufacturer’s instruc-
tions. According to the standard curve, the mean quantity of
the non-digested and SalI-digested molecules was calculated
automatically from software. To correctly estimate the
mutation frequency of AP sites and derivatives, the Taq
polymerase-induced mutation frequency was subtracted as
background and the mutation frequency was calculated as
follows: (number of mutated molecules/total number of
molecules) · 100 (for details see Supplementary Figures 1
and 2).
RESULTS
Development of the experimental system
The experimental strategy is depicted in Figure 1A. pC2/HX
plasmid molecules, which contain a single hypoxanthine (HX)
within the SalI recognition sequence, were constructed by
in vitro DNA replication. The characterization of the single
lesion-containing vector was performed by constructing
32P-labelled plasmid molecules, as described previously
(22). The incubation of pC2/HX DNA with ANPG followed
by digestion with E.coli endonuclease III revealed a complete
conversion of covalently closed circular molecules to nicked
form (data not shown), thus conﬁrming that all molecules
contained a single HX. The abasic site and its derivatives,
50 and 30 ssb (Figure 1B), were obtained by digestion of
these molecules with the appropriate enzymes. The prepara-
tion of lesion-containing plasmids closely preceded cell trans-
fection in order to minimize the problem of instability of BER
intermediates. The single lesion-containing vectors were tran-
siently transfected into simian cells and the vector progeny
was isolated. The rescued pC2 DNA molecules were extens-
ively digested with SalI and the molecules resistant to cleav-
age (mutant molecules) were selectively ampliﬁed by PCR.
The ampliﬁed product was extracted from the gel, digested
again with SalI and then subcloned into pCR II vector for
sequence analysis. To calculate the mutation frequency
induced by the different lesions a quantitative PCR (QPCR)
analysis was performed.
In order to validate the system, two types of plasmid, one
containing the unmodiﬁed SalI sequence (negative control)
and one containing a single HX residue (positive control),
were subjected to all the procedures, and mutation type and
frequency were determined. Mutation analysis of the unmodi-
ﬁed plasmid revealed the occurrence of point mutations
with GC>AT transitions as predominant class (57%). Muta-
tions were spread along the entire SalI recognition sequence.
4406 Nucleic Acids Research, 2005, Vol. 33, No. 14The site where the lesion was originally built (the adenine of
the SalI site) was a cold spot of mutation (Figure 2A). Muta-
tionfrequencywasintheorderof0.4%(0.14and0.63%intwo
independent experiments) (Table 1). The type of mutations
detected is in agreement with the mutational properties of
Taq polymerase.
When the progeny of the HX-containing vectors was ana-
lysed, only point mutations, exclusively AT>GC transitions,
were detected. The totality of mutation events mapped where
the lesion was originally located (Figure 2B) and the muta-
tion frequency was 7.2% (7 and 7.4% in two independent
experiments). AT>GC transversions are indeed expected to
arise following replication into mammalian cells of HX-
containing vectors. The high mutagenic potential of this
deaminated purine is in agreement with previous studies
showing both a poor HX-DNA glycosylase activity in vivo
and the high miscoding potential of this lesion (23).
Mutation spectrum of BER intermediates
Abasic sites. The speciﬁcity and sensitivity of our experi-
mental strategy prompted us to investigate the miscoding
properties of the AP sites in mammalian cells. pC2/HX
molecules were incubated with ANPG immediately before
transfection to generate shuttle vectors with a single natural
AP site at a known position of their genome. Point mutations
were the predominant event occurring at the AP sites
(Figure 3A) in the rescued shuttle vector progeny. A small
proportion (16%) of deletions was also observed, the majority
spanning between 8 and 168 bp. Similarly to what observed in
the case of HX, all point mutations mapped where the AP site
was originally located. Among the point mutations, transver-
sions were the predominant events (61%): both AT>TA (48%)
and AT>CG (13%) base substitutions were recovered. The
remaining mutations were AT>GC transitions. The mutation
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Figure 1. Experimental procedure. (A) Construction of an SV40-derived single lesion-containing shuttle vector. Single adducted double-stranded DNA molecules
wereobtainedbyinvitroreplicationreactions.ThesinglelesionwaslocatedwithintherecognitionsequenceofSalItoallowtherecoveryofmutantsbyRFLP/PCR
technique.COScellsweretransientlytransfectedfor72handlowmolecularweightplasmidDNAwasrescuedbyHirtprocedure.AfterextensiveSalIdigestion,the
mutated/resistant molecules were amplified by PCR. The amplified products were purified, cloned and sequenced to determine the mutation spectrum. Mutation
frequency was estimated by QPCR. (B) Formation of repair intermediates during BER. Modified DNA bases are cleaved by the action of monofunctional or
bifunctional DNA glycosylases to produce an AP site. 50-deoxyribose-5-phosphate (50dRp) and 30-[2,3-didehydro-2,3-dideoxy-ribose] (30ddR5p) single-strand
breaks are obtained via APE 1-mediated hydrolysis and b-elimination reactions, respectively.
Nucleic Acids Research, 2005, Vol. 33, No. 14 4407spectrum (Figure 3B) revealed that dAMP (48%) and dCMP
(39%) were preferentially misincorporated opposite the AP
site, whereas the incorporation of dGMP was a rare event.
In our vector, the incorporation of TMP could not be detected
since it restores the wild-type sequence. No frameshift events
werefound;however,itshouldbenoticed thatinourvectorthe
abasic site is located in sequence context unfavourable to
frameshift mutations.
TheAP site mutation proﬁle observed supportsthe so-called
‘A-rule’ model, i.e. the preferential insertion of an adenine
opposite an AP site. The template realignment mechanism
could also be evoked (see Discussion).
50 dRp. During BER, the base loss sites are converted into ssb
by the action of 50AP endonucleases, which lead to the forma-
tion of 50dRp and 30 hydroxyl termini. In order to investigate
the speciﬁc mutagenic properties of the 50dRp intermediate,
pC2/HX plasmid molecules, previously digested by ANPG
and subsequently by APE 1, were transfected in COS cells.
The molecular analysis of the 50dRp-induced mutations
revealed that the majority of events were point mutations
(91%) with a high prevalence of transversions (87%)
(Figure 4A). A small proportion (9%) of deletions, which
were spanning between 1 and 39 bp, was also found. In
contrast to what observed with the AP site, both dATP and
dGTP were inserted opposite this intermediate with a similar
efﬁciency (46 and 41% of the total events, respectively). A
very low frequency of dCTP incorporation was observed
(Figure 4B).
30 ddR5p. Because of the instability of the aldehyde, AP sites
can be spontaneously converted to ssb by b-elimination
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Figure 2. Spontaneous and hypoxanthine-induced mutation spectrum. Distri-
bution of point mutations along the SalI-recognition sequence of (A) unda-
maged and (B) hypoxanthine-containing shuttle vectors, after replication
into COS cells. The bold A indicates the position where hypoxanthine was
originally built.
Table 1. Mutation frequency (%)
Experiment 1 Experiment 2 Mean value
Control 0.63 0.14 0.38
HX 7.00 7.40 7.20
AP site 3.80 2.90 3.30
50dRp 3.70 3.70 3.70
30ddR5p 3.00 5.00 4.00
AP site A
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deletions
0
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AC GT
nucleotide incorporation
% %
Figure 3. APsite-inducedmutationspectrum.(A)Distributionofmutationsby
type and frequency. (B) Preferential nucleotide insertion opposite the AP site.
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Figure 4. 50dRp-induced mutation spectrum. (A) Distribution of mutations
by type and frequency. (B) Preferential nucleotide insertion opposite the
50dRp ssb.
4408 Nucleic Acids Research, 2005, Vol. 33, No. 14reaction and give rise to 30ddRp and 50 phosphate termini. The
same termini are generated by the action of the 30lyase activity
associated with bifunctional DNA glycosylases, such as
OGG1, TDG, etc. In order to study the mutagenic potential
of this 30 modiﬁed terminus, pC2/HX plasmid molecules,
previously digested by ANPG and subsequently by E.coli
endonuclease III, were transfected in COS cells. Similarly
to what observed with the 50ssb, the mutation spectrum
induced by this intermediate was characterized by the dom-
inance of point mutations (61%), mainly transversions (78%)
(Figure 5A). The analysis of the base inserted opposite the
30ddRp showed a strong bias in favour of adenine, following
the order dATP>dCTP ¼ dGTP (55, 22.5 and 22.5%, respect-
ively) (Figure 5B).
Mutation frequencies at BER intermediates
The mutagenic potential of the BER intermediates was evalu-
ated by QPCR analysis. Table 1 summarizes the results of
two independent experiments per each lesion. The mutation
frequency detected at the SalI site of the undamaged and the
HX-containing plasmids are shown for comparison.
Similar mutation frequencies were reported for AP, 50dRp
and 30ddR5P residues: 3.3, 3.7 and 4%, respectively.
The mutation frequency for the abasic site is in agreement
with previously reported data (17). The high mutagenic poten-
tial of 50 and 30 ssb suggests that the persistence of these
intermediates might be a threat for genome stability.
DISCUSSION
BER leads to the formation of several DNA repair interme-
diates that, if unsolved at replication, may threaten genomic
stability by serving as blocks to replication, by stalling RNA
polymerase and by promoting topoisomerase II-mediated
double-strand breaks. In this study we have speciﬁcally
addressed the mutagenicity of abasic sites and derivatives
by using a single lesion-containing vector transfected into
mammalian cells. We show that QPCR is a valuable tool to
precisely quantify mutant rescue.
The molecular analysis of the mutations induced by natural
AP sites showed that point mutations are the predominant
events. A slight bias for the preferential insertion of an adenine
was observed. These data are consistent with mechanistic
studies of primer extension catalysed by puriﬁed mammalian
DNA polymerases (16) and mutagenesis studies in both E.coli
and mammalian cells (24). In particular, in mammalian cells,
a preferential incorporation of an adenine opposite a synthetic
abasic site was reported by replication of a single lesion-
containing oligonucleotide (16) and, more recently, by a
quantitative assay for TLS across a THF residue (25). One
study(17) did not ﬁnd any speciﬁc base incorporation opposite
AP site. Sequence-speciﬁc effects might explain this discrep-
ancy. Pioneer NMR spectroscopy studies on DNA duplexes
containing a single AP site provide a possible mechanistic
explanation for the ‘A-rule’. Structure analysis of these
duplexes showed that only when an adenine was inserted, the
base was within the double helix and DNA b-conﬁguration
was retained, while the insertion of a pyrimidine produced a
DNA collapsed structure with the lesion situated out of the
helix (26).
We observed that, after adenine, the most frequently mis-
incorporated base opposite the AP site is a cytosine. A well-
established model for AP site-induced mutagenesis predicts
that replicative DNA polymerase might loop out the lesion
and use the 50 neighbouring base to the abasic site to instruct
nucleotide incorporation, (‘50-rule’). According to this model,
the nature of base substitution should be driven by the speciﬁc
50 ﬂanking base used as template. The high frequency of
AT>GC transitions due to cytosine incorporation opposite
the AP site observed in this study might be ascribed to this
mechanism.
Which is the DNA polymerase involved in AP site bypass?
Some lines of evidence suggest that human DNA pol h, ﬁrst
characterized for the error free bypass of cyclobutane pyrimi-
dine dimers, might be involved. In particular, the order and
the ratio of dNTPs insertion opposite an abasic site was G >
A > C > T (51%-39%-6%-4%) while the frequency extension
from different 30-terminal dNTPs/AP site was A > C > G > T
(52%-20%-18%-10%) (14). More recently, besides pol h,
an archaeal Y-polymerase homologue of human pol k, Dpo4,
was shown to efﬁciently bypass the abasic sites by a strong
preferential adenine incorporation (20,27).
Alltogether,thesedata leadtoamodelwhere thereplicative
DNA polymerase stalled to the AP site could rarely manage
to incorporate a base and, if it does, an adenine should be
incorporated opposite the lesion (‘A-rule’) but without any
extension. This reaction should be accomplished by a TLS
DNA polymerase, likely pol h or pol k that synthesizes
several nucleotides until resuming of regular replication (28).
The AP site-induced mutation spectrum that others and we
have reported in mammalian cells perfectly ﬁts to this model.
Several reports suggested that natural abasic sites might
also promote 1- and 2-base deletions (16,20). NMR studies
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Figure 5. 30ddR5p-induced mutation spectrum. (A) Distribution of mutations
by type and frequency. (B) Preferential nucleotide insertion opposite the
30ddR5p ssb.
Nucleic Acids Research, 2005, Vol. 33, No. 14 4409clariﬁed that a slipped intermediate with the lesion looped
out of the helix could also arise after adenine incorporation
but speciﬁc sequence context was required (a thymidine
positioned 50 to abasic site) to stabilize such a structure and
potentially to lead to frameshift mutations (29). The speciﬁc
sequence constrain for AP site-induced frameshifs could
justify the absence of this type of mutations in the present
study.
The surprising ﬁnding of this study is the detection of point
mutations after in vivo replication of vector molecules con-
taining a single 50dRp or 30ddR5p residue. Mutation frequency
was very high and comparable with that of AP sites ( 3–4%).
When the replication machinery encounters these termini, it is
expected that a block of replication occurs leading to lethality
(30,31). Our experimental system has not been designed to
measure lethal events. Therefore, we cannot exclude that, if
these termini act as strong blocks to replication, we could have
an overestimation of the observed mutation frequency and a
potential bias on mutation spectrum. Previous studies have
addressed the mutagenic potential of ssb in human cells by
using nicked pZ189 shuttle vector molecules as a tool (32).
Base substitutions were predominantly detected and were
assigned to error-prone DNA repair synthesis at the nick/
gap sites. For long time, the low ﬁdelity of pol b has been
implicated as potential source for mutations arising during
BER synthesis. The ability of several DNA polymerases,
including replicative pols, to perform gap-ﬁlling reactions
(33,34), and the discovery of the proof-reading activity of
A P E1o n3 0 mispaired DNA lead to exclude a relevant con-
tribution of repair synthesis to mutagenesis. In addition, recent
studies showed that during BER synthesis single nucleotide
deletions were predominantly generated and the mutation
frequency was approximately equal to 1 · 10
3 (11). The
formation of dsb at unrepaired non-canonical ssb might trigger
recombination events; however, TLS is more likely to account
for the high mutation frequency and the predominance of point
mutations at BER intermediates that we observed (35,36).
Only the availability of mutant cell lines will clarify the rel-
ative contribution of different pathways to in vivo mutagenesis
of BER intermediates. Interestingly, pol b null cells, which
accumulate unrepaired 50dRp residues, have been reported to
exhibit a speciﬁc increase in both spontaneous and MMS-
induced transversions compared with wild-type cells (10).
The mutation analysis revealed a preferential insertion of pur-
ines opposite the candidate abasic sites due to the removal of
N-methylpurines. The high proportion of transversions and the
similar insertion frequencies of adenine and guanine are also a
hallmark of our 50dRp-induced mutation spectrum. We hypo-
thesizethatarescueofastalledreplicationforkmightoccurby
a low-ﬁdelity DNA polymerase at 50dRP residues (as well as at
30dd5Rp) leading to mutational events. If our hypothesis is
correct, this might be of biological relevance considering that
the high steady state level of AP sites (9000 AP sites/cell/day)
arise mainly from oxidized abasic sites, which are known
to be 50 incised (50dRp) and inefﬁciently repaired by pol b-
dependent SP-BER.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
ACKNOWLEDGEMENTS
The authors thank Giovanni Maga and Barbara Pascucci for
helpful discussions. This work was partially supported by
Compagnia di S. Paolo, Turin, Italy (Project coordinator:
Dr G. Frosina) and Progetto Ministero della Salute-Ricerca
Finalizzata 2003 ‘Stabilita ` del genoma: bersagli molecolari
nella prevenzione e nel controllo delle neoplasie’. Funding
to pay the Open Access publication charges for this article
was provided by Istituto Superiore di Sanita `, Rome, Italy.
Conflict of interest statement. None declared.
REFERENCES
1. Fortini,P., Pascucci,B., Parlanti,E., D’Errico,M., Simonelli,V. and
Dogliotti,E. (2003) The base excision repair: mechanisms and its
relevance for cancer susceptibility. Biochimie, 85, 1053–1071.
2. Krokan,H.E., Standal,R. and Slupphaug,G. (1997) DNA glycosylases in
the base excision repair of DNA. Biochem. J., 325, 1–16.
3. Nakamura,J., La,D.K. and Swenberg,J.A. (2000) 50-Nicked apurinic/
apyrimidinic sites are resistant to beta-elimination by beta-polymerase
and are persistent in human cultured cells after oxidative stress. J. Biol.
Chem., 275, 5323–5328.
4. Wilson,S.H. and Kunkel,T.A. (2000) Passing the baton in base excision
repair. Nature Struct. Biol., 7, 176–178.
5. Caldecott,K.W. (2003) XRCC1 and DNA strand break repair. DNA
Repair, 2, 955–969.
6. Lavrik,O.I., Prasad,R., Sobol,R.W., Horton,J.K., Ackerman,E.J. and
Wilson,S.H.(2001)Photoaffinitylabelingofmousefibroblastenzymesby
a base excision repair intermediate. J. Biol. Chem., 276,
25541–25548.
7. Roth,R.B. and Samson,L.D. (2002) 3-Methyladenine DNA glycosylase-
deficient Aag null mice display unexpected bone marrow alkylation
resistance. Cancer Res., 62, 656–660.
8. Sobol,R.W., Horton,J.K., Kuhn,R., Gu,H., Singhal,R.K., Prasad,R.,
Rajewsky,K. and Wilson,S.H. (1996) Requirement of mammalian DNA
polymerase-B in base-excision repair. Nature, 379, 183–186.
9. Slupphaug,G., Kavli,B. and Krokan,H.E. (2003) The interacting
pathways for prevention and repair of oxidative DNA damage. Mutat.
Res., 531, 231–251.
10. Sobol,R.W., Watson,D.E., Nakamura,J., Yakes,F.M., Hou,E.,
Horton,J.K.,Ladapo,J.,VanHouten,B.,Swenberg,J.A.,Tindall,K.R.etal.
(2002) Mutations associated with base excision repair deficiency and
methylation-induced genotoxic stress. Proc. Natl Acad. Sci. USA, 99,
6860–6865.
11. Bennett,S.E., Sung,J.S. and Mosbaugh,D.W. (2001) Fidelity of uracil-
initiated base excision DNA repair in DNA polymerase b proficient and
deficient mouse embryonic fibroblast cell extracts. J. Biol. Chem., 276,
42588–42600.
12. Zhang,Q.-M. and Dianov,G.L. (2005) DNA repair fidelity of base
excisionrepairpathwaysinhumancellextracts.DNArepair,4,263–270.
13. Zhang,Y., Yuan,F., Wu,X., Rechkoblit,O., Taylor,J.S., Geacintov,N.E.
and Wang,Z. (2000) Error-prone lesion bypass by human DNA
polymerase eta. Nucleic Acids Res., 28, 4717–4724.
14. Haracska,L., Kondratick,C.M., Unk,I., Prakash,S. and Prakash,L. (2001)
InteractionwithPCNAisessentialforyeastDNApolymerasehfunction.
Mol. Cell, 8, 407–415.
15. Gibbs,P.E.M. and Lawrence,C.W. (1995) Novel mutagenic properties
of abasic sites in Saccharomyces cerevisiae. J. Mol. Biol., 251,
229–236.
16. Shibutani,S., Takeshita,M. and Grollman,A.P. (1997) Translesional
synthesisonDNAtemplatescontainingasingleabasicsite.J.Biol.Chem.,
272, 13916–13922.
17. Gentil,A., Cabral Neto,J.B., Mariage-Samson,R., Margot,A.,
Imbach,J.L., Rayner,B. and Sarasin,A. (1992) Mutagenicity of a unique
apurinic/apyrimidinic site in mammalian cells. J. Mol. Biol., 227,
981–984.
18. Lehmann,A.R.(2002)ReplicationofdamagedDNAinmammaliancells:
new solutions to an old problem. Mutat. Res., 509, 23–34.
4410 Nucleic Acids Research, 2005, Vol. 33, No. 1419. Haracska,L., Washington,M.T., Prakash,S. and Prakash,L. (2001)
InefficientbypassofanabasicsitebyDNApolymeraseh.J.Biol.Chem.,
276, 6861–6866.
20. Kokoska,R.J., McCulloch,S.D. and Kunkel,T.A. (2003) The efficiency
and specificity of apurinic/apyrimidinic site bypass by human DNA
polymerase eta and Sulfolobus solfataricus Dpo4. J. Biol. Chem., 278,
50537–50545.
21. Fortini,P., Pascucci,B., Parlanti,E., Sobol,R.W., Wilson,S.H. and
Dogliotti,E. (1998) Different DNA polymerases are involved in the
short- and long-patch base excision repair in mammalian cells.
Biochemistry, 37, 3575–3580.
22. Fortini,P., Parlanti,E., Sidorkina,O.M., Laval,J. and Dogliotti,E. (1999)
The type of DNA glycosylase determines the base excision
repair pathway in mammalian cells. J. Biol. Chem., 274,
15230–15236.
23. Hill-Perkins,M., Jones,M.D. and Karran,P. (1986) Site-specific
mutagenesis in vivo by single methylated or deaminated purine bases.
Mutat. Res., 162, 153–163.
24. Lawrence,C.W., Borden,A., Banerjee,S. and Le Clerc,J.E. (1990)
Mutation frequency and spectrum resulting from a single abasic site in a
single-stranded vector. Nucleic Acids Res., 18, 2153–2157.
25. Avkin,S., Adar,S., Blander,G. and Livneh,Z. (2002) Quantitative
measurement of translesion replication in human cells: evidence for
bypassofabasicsitesbyareplicativeDNApolymerase.Proc.NatlAcad.
Sci. USA, 99, 3764–3769.
26. Cuniasse,P., Fazakerley,G.V., Guschlbauer,W., Kaplan,B.E. and
Sowers,L.C. (1990) The abasic site as a challenge to DNA polymerase a
nuclear magnetic resonance study of G, C, nd T opposite a model abasic
site. Biochemistry, 213, 303–314.
27. Ling,H., Boudsocq,F., Woodgate,R. and Yang,W. (2004) Snapshots of
replicationthroughanabasiclesion:structuralbasisforbasesubstitutions
and frameshifts. Mol. Cell, 13, 751–762.
28. Fleck,O. and Schar,P. (2004) Translesion DNA synthesis: little fingers
teach tolerance. Curr. Biol., 14, R389–R391.
29. Lin,Z., Hung,K.N., Grollman,A.P. and los Santos,C. (1998) Solution
structure of duplex DNA containing an extrahelical abasic site analog
determined by NMR spectroscopy and molecular dynamics. Nucleic
Acids Res., 26, 2385–2391.
30. Boiteux,S. and Guillet,M. (2004) Abasic sites in DNA: repair and
biological consequences in Saccharomyces cerevisiae. DNA Repair, 3,
1–12.
31. Hanna,M., Chow,B.L., Morey,N.J., Jinks-Robertson,S., Doetsch,P.W.
and Xiao,W. (2004) Involvement of two endonuclease III homologs in
the base excision repair pathway for the processing of DNA
alkylation damage in Saccharomyces cerevisiae. DNA Repair, 3, 51–59.
32. Dar,M.E. and Jorgensen,T.J. (1995) Deletions at short direct repeats and
base substitutions are characteristic mutations for bleomycin-induced
double- and single-strand breaks, respectively, in a human shuttle vector
system. Nucleic Acids Res., 23, 3224–3230.
33. Frosina,G., Fortini,P., Rossi,O., Carrozzino,F., Raspaglio,G., Cox,S.L.,
Lane,P.D., Abbondandolo,A. and Dogliotti,E. (1996) Two pathways
for base excision repair in mammalian cells. J. Biol. Chem., 271,
9573–9578.
34. Chou,K.M. and Cheng,Y.C. (2002) An exonucleolytic activity of human
apurinic/apyrimidinic endonuclease on 30 mispaired DNA. Nature, 415,
655–659.
35. Pascucci,B., Russo,M.T., Crescenzi,M., Bignami,M. and Dogliotti,E.
(2005) The accumulation of MMS-induced single strand breaks in G1
phase is recombinogenic in DNA polymerase {beta} defective
mammalian cells. Nucleic Acids Res., 33, 280–288.
36. Sobol,R.W., Kartalou,M., Almeida,K.H., Joyce,D.F., Engelward,B.P.,
Horton,J.K., Prasad,R., Samson,L.D. and Wilson,S.H. (2003) Base
excision repair intermediates induce p53-independent cytotoxic and
genotoxic responses. J. Biol. Chem., 278, 39951–39959.
Nucleic Acids Research, 2005, Vol. 33, No. 14 4411